Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A RaPID Macrocyclic Peptide Inhibitor of ROR1/2 Strongly Reduces Proliferation of Diffuse Intrinsic Pontine Glioma Cells. | ACS Chem Biol | 2026 | 42260911 | PubTator, text mining | PubMed |
| Circulating plasma protein biomarkers associated with risk of negative clinical outcomes in virally suppressed people with HIV receiving medications for opioid use disorder. | Front Mol Biosci | 2026 | 42131086 | PubTator, text mining | PubMed |
| Targeting ROR1 with humanized antibody drug conjugates and cytokine fusion proteins for cancer therapy. | iScience | 2026 | 42023144 | PubTator, text mining | PubMed |
| Correction to "Development of Novel Peptide-Based 68Ga-Labeled Radiotracers for Detecting ROR1 Expression in Tumors". | Mol Pharm | 2026 | 41940953 | PubTator, text mining | PubMed |
| Research progress of mesenchymal stem cells/stromal cells and their derivatives against cell senescence in the treatment of osteoarthritis. | Ann Med | 2026 | 41919394 | PubTator, text mining | PubMed |
| Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies. | Cancers (Basel) | 2026 | 41899515 | PubTator, text mining | PubMed |
| Dysregulation of SIRT1, polyamines and miRNA editing in cancer and aging. | Amino Acids | 2026 | 41863647 | PubTator, text mining | PubMed |
| A glycoengineered anti-ROR1 antibody, GE-zilovertamab, selectively enhances antibody-dependent cellular cytotoxicity against chronic lymphocytic leukemia. | Antib Ther | 2026 | 41804382 | PubTator, text mining | PubMed |
| Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment. | Front Oncol | 2026 | 41800053 | PubTator, text mining | PubMed |
| Revolutionizing protein degradation: Harnessing nanoparticles for PROTAC delivery. | Mater Today Bio | 2026 | 41782993 | PubTator, text mining | PubMed |
| CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond. | Cancer Metastasis Rev | 2026 | 41770377 | PubTator, text mining | PubMed |
| PROTAC-based protein degradation: a window of opportunity for melanoma therapy. | J Biomed Sci | 2026 | 41761284 | PubTator, text mining | PubMed |
| miR-137-5p-Loaded Milk-Derived Small Extracellular Vesicles Modulate Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammatory Responses in an In Vitro Alzheimer's Disease Model. | Pharmaceutics | 2026 | 41754992 | PubTator, text mining | PubMed |
| Advances in Breast Cancer Research: Immunological, Pathological, and Pharmacological Perspectives for Improving Patient Outcomes. | Int J Mol Sci | 2026 | 41752040 | PubTator, text mining | PubMed |
| Molecular Pathogenesis and Targeted Treatment of Richter Transformation. | Biomedicines | 2026 | 41751246 | PubTator, text mining | PubMed |
| ROR1-PI3K/AKT signaling drives adaptive resistance to cell cycle blockade in TP53 mutated ovarian cancer. | Cell Death Dis | 2026 | 41748546 | PubTator, text mining | PubMed |
| Dual Roles of NIX/BNIP3L in Tumors: Friend or Foe. | Biology (Basel) | 2026 | 41744611 | PubTator, text mining | PubMed |
| Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics. | Cancer Lett | 2026 | 41730382 | PubTator, text mining | PubMed |
| Advances in T cell-based immunotherapy for osteosarcoma. | Front Immunol | 2026 | 41727478 | PubTator, text mining | PubMed |
| Universal Baseline for in vitro Selection of Genetically Encoded Libraries. | bioRxiv | 2026 | 41727091 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=2